Skip to main content
. 2021 Jul 30;8:661222. doi: 10.3389/fmolb.2021.661222

TABLE 1.

General overview of pathology quality control characteristics in our cohort (N = 931) divided by baseline (N = 608) and post-treatment (N = 323) core needle biopsies.

Biopsy timepoint Status N Characteristic of the sample, median percentage
Tumor area Malignant cells Fibrosis Necrosis
Baseline Included 547 95 60 20 10
Excluded 61 0 0 90 5
Post-treatment Included 261 20 50 25 25
Excluded 62 10 5 10 90